DrugPatentWatch Database Preview

Covis Company Profile

COVIS has fourteen approved drugs.

There are ten US patents protecting COVIS drugs.

There are fifty-nine patent family members on COVIS drugs in twenty countries and twelve supplementary protection certificates in eight countries.

Subscribe to access the full database, or Get Started for $10
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Covis	RILUTEK	riluzole	TABLET;ORAL	020599-001	Dec 12, 1995	AB	RX	Yes	Yes		Get Started for $10				Get Started for $10
Covis	ZETONNA	ciclesonide	AEROSOL, METERED;NASAL	202129-001	Jan 20, 2012		RX	Yes	Yes	8,371,292	Get Started for $10				Get Started for $10
Covis	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-001	Aug 29, 2002	AB	RX	Yes	No		Get Started for $10				Get Started for $10
Covis	MAKENA	hydroxyprogesterone caproate	SOLUTION;INTRAMUSCULAR	021945-001	Feb 3, 2011	AP1	RX	Yes	Yes		Get Started for $10				Get Started for $10
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Get Started for $10
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Covis	ZETONNA	ciclesonide	AEROSOL, METERED;NASAL	202129-001	Jan 20, 2012	6,120,752	Get Started for $10
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-002	Jun 26, 2002	5,916,595	Get Started for $10
Covis	OMNARIS	ciclesonide	SPRAY, METERED;NASAL	022004-001	Oct 20, 2006	8,383,611	Get Started for $10
Covis	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009	8,591,864	Get Started for $10
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	30 mg/mL, 17 mL single-use vials	➤ Subscribe	2015-12-04
➤ Subscribe	Extended-release Tablets	20 mg and 30 mg	➤ Subscribe	2007-11-07
➤ Subscribe	Extended-release Tablets	40 mg	➤ Subscribe	2007-06-11
➤ Subscribe	Capsules	2 mg, 4 mg and 6 mg	➤ Subscribe	2007-08-10
➤ Subscribe	Nasal Spray	250 mcg	➤ Subscribe	2012-02-13
➤ Subscribe	Extended-release Tablets	25.5 mg and 34 mg	➤ Subscribe	2008-11-28
➤ Subscribe	Extended-release Tablets	8.5 mg and 17 mg	➤ Subscribe	2009-03-02

Subscribe to access the full database, or Get Started for $10
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1169062	CA 2012 00050	Denmark	Get Started for $10
1169062	92114	Luxembourg	Get Started for $10	PRODUCT NAME: FERUMOXYTOL
1169062	300558	Netherlands	Get Started for $10	PRODUCT NAME: FERUMOXYTOL IN IEDERE DOOR HET BASISOCTROOI BESCHERMDE VORM; REGISTRATION NO/DATE: EU/1/12/774/001-002 20120615
0124495	SPC/GB01/006	United Kingdom	Get Started for $10	PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.